122310 — Genoray Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeMicro CapSuper Stock

Annual cashflow statement for Genoray Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	10,172	14,323	13,900	12,356	-2,537
Depreciation
Amortisation
Non-Cash Items	1,828	2,182	2,274	679	13,513
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-6,757	-4,683	-4,970	-13,758	-4,956
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	8,507	15,383	14,837	3,555	13,274
Capital Expenditures	-4,280	-8,908	-13,779	-8,599	-6,292
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	1,516	-3,384	-7,841	9,159	7,715
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-2,764	-12,293	-21,621	560	1,423
Financing Cash Flow Items	-1,025	—	—	—	55.3
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-1,781	-1,593	-8,156	-3,706	-3,847
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	3,954	1,544	-14,961	116	11,014